TP53 and non-small cell lung carcinoma: Lumichrome has proven anti-cancer activity in non-small-cell lung cancer (NSCLC) cell lines by suppressing growth and inducing apoptosis through p53-dependent mechanisms at concentrations above 25 μM [30].